uksi/2020/469 — The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2020

2020 No. 469 National Health Service, England The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2020 Made 28th April 2020 Laid before Parliament 29th April 2020 Coming into force 20th May 2020 The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 6E(1) and (2) and sections 272(7) and (8) of the National Health Service Act 2006 . Citation and commencement 1 These Regulations may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2020 and come into force on 20th May 2020. Amendment of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 2 1 The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 are amended as follows. 2 In regulation 20 (interpretation)— a in the definition of “flat rate payment”, for “£165.56” substitute “£183.92”; and b in the definition of “high band payment”, for “£227.77” substitute “£253.02”. Signed by authority of the Secretary of State for Health and Social Care Helen Whately Parliamentary Under Secretary of State, Department of Health and Social Care 28th April 2020 EXPLANATORY NOTE (This note is not part of the Regulations) The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities’ and Standing Rules) Regulations 2012 ( S.I. 2012/2996 ) (“Standing Rules”) make provision for, amongst other things, NHS funded nursing care. These Regulations amend regulation 20 of the Standing Rules. The amendments made by regulation 2(2) increase the rates for NHS funded nursing care payment by the National Health Service Commissioning Board or a clinical commissioning group. A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sector is foreseen.